Breaking News, Business, Financial and Economic News, World News from EconoTimes

Become a contributor

Bookmark Econotimes

Fri, Apr 4, 2025 01:32 AM All times are UTC

Follow Series

©Econometrics LLC 2025. All Rights Reserved.

Gideon Lasco

PhD candidate in Medical Anthropology, Amsterdam Institute for Social Science Research (AISSR), University of Amsterdam

Gideon Lasco, MD, MSc is a licensed physician, medical anthropologist, and writer from the Philippines. He received his medical degree from the University of the Philippines College of Medicine in 2010, and completed his MSc Medical Anthropology in the same college in 2014. He is currently taking up a PhD in medical anthropology at the University of Amsterdam's Amsterdam Institute of Social Science Research (AISSR). A regular op-ed contributor at the Philippine Daily Inquirer, his essays have been published in the Singapore Straits Times, Jakarta Post, China Post, and other regional newspapers.

His research has focused on the traditional and modern ways that various sectors of society utilise to improve their bodies and their everyday lives. In 2011, he traveled around the Philippines to interview over forty traditional healers from various cultural traditions and observe their ways of healing. From 2012 to 2013, he did ethnographic work on young drug users in an urban poor community. His ongoing PhD research is about the meanings and materialities of height (human stature) in the Philippines.

In the Philippines, the premium placed on height is no tall tale

Apr 04, 2017 14:12 pm UTC| Insights & Views Economy

During the 1936 Berlin Olympics the first time basketball was played as an Olympic sport the Philippine mens basketball team was a surprisingly strong contender. Largely seen as underdogs because of their short stature,...

Southeast Asia's war on drugs doesn’t work – here's what does

Dec 21, 2016 07:10 am UTC| Insights & Views Life

Philippine President Rodrigo Dutertes bloody war on drugs is just the latest in a region where drug use has usually been met with draconian measures. Thailand embarked 13 years ago on a drug war that strikes eerie...

Tall, pale and handsome: why more Asian men are using skin-whitening products

Nov 25, 2016 10:30 am UTC| Insights & Views Life

Jose, 19, is a college student in Puerto Princesa City, Philippines. On a regular school day, after he wakes up, he takes a shower, scrubbing his body using soap made of papaya (Carica papaya), a fruit thats said to...

Economy

U.S. Imposes 26% Tariff on Indian Imports, Spares Pharma Sector

The U.S. has imposed a 26% tariff on imports from India, dealing a blow to New Delhis hopes for leniency under President Donald Trumps global trade policies. A baseline 10% tariff begins Saturday, with the full rate...

South Korea Scrambles to Mitigate Impact of Harsh U.S. Tariffs on Exports

South Koreas acting President Han Duck-soo has ordered emergency support measures for industries affected by sweeping new U.S. tariffs, including a 25% tariff on Korean automobile exports. The move follows President Donald...

Australia Criticizes Trump’s 10% Tariff, Rules Out Retaliation

Australian Prime Minister Anthony Albanese has condemned U.S. President Donald Trumps decision to impose a 10% tariff on Australian imports, calling it not the act of a friend. The move impacts Australian beef exports,...

Australia’s Trade Surplus Drops to Four-Year Low on Weak Exports, Strong Imports

Australias trade surplus plummeted to its lowest level in over four years in February, as a sharp drop in exports and a rise in imports dealt a double blow to the countrys trade performance. The trade balance came in at...

Japan's Nikkei Tumbles as Trump Slaps 24% Tariff on Japanese Goods

Japans Nikkei 225 plunged to an eight-month low on Thursday after U.S. President Donald Trump announced sweeping reciprocal tariffs, including a 24% duty on Japanese imports. The index dropped as much as 4.6% in early...

Politics

Senate Passes Bill to Block Trump’s Canada Tariffs Despite GOP Resistance

In a sharp rebuke to President Donald Trump, the U.S. Senate passed a bill on Wednesday to halt newly proposed tariffs on Canada, just hours after Trump announced sweeping duties on global imports. The bill, approved...

Disability Rights Groups Sue Trump, Musk Over Social Security Cuts

Disability rights organizations and Social Security recipients have filed a federal lawsuit against the Trump administration and billionaire Elon Musk, accusing them of illegally slashing the Social Security...

Canada Vows Strong Response to Trump’s Tariffs

Canada will take decisive action against U.S. President Donald Trumps recently imposed tariffs, Prime Minister Mark Carney announced on Wednesday. Speaking to reporters before a high-level cabinet meeting, Carney...

Trump Imposes 10% Reciprocal Tariffs, Targets China and EU

President Donald Trump announced sweeping new tariffs aimed at addressing what he calls unfair trade practices by foreign nations. Starting April 5, a baseline 10% reciprocal tariff will be imposed on all imported goods...

French Judge Faces Threats After Barring Marine Le Pen from 2027 Presidential Race

French judge Benedicte de Perthuis is under police protection after barring far-right leader Marine Le Pen from running in Frances 2027 presidential election. De Perthuis, who led the three-judge panel that found Le Pen...

Science

AstraZeneca’s Imfinzi Gets US Approval for Bladder Cancer Treatment

AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder cancer, a significant advancement in cancer therapy. The approval allows Imfinzi to be used in...

Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing

The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY). Designed for patients aged 12 and older with hemophilia A or B,...

FDA Vaccine Chief Peter Marks Resigns Amid Controversy Over Transparency

Peter Marks, the U.S. Food and Drug Administrations (FDA) top vaccine official, has resigned after reportedly being forced out by the Department of Health and Human Services (HHS), according to The Wall Street Journal....

What are the chances an asteroid will impact Earth in 2032?

For a few days in mid-February, headlines around the world buzzed about the potential for an asteroid to hit the Earth in 2032 specifically, asteroid 2024 YR4. The chance of this impact rose to a high of 3.1 per cent on...

A new study reveals the structure of violent winds 1,300 light years away

The planet WASP-121b is extreme. Its a gas giant almost twice as big as Jupiter orbiting extremely close to its star50 times closer than the Earth does around the Sun. WASP-121b is so close to its star that tidal forces...

Technology

Nintendo Switch 2 Launches June 5 at $449.99 with Major Upgrades

Nintendo (NYSE:SWCH) has officially announced the launch of its next-generation gaming console, the Switch 2, set for release on June 5. Priced at $449.99 in the U.S., the highly anticipated device features significant...

ReliaQuest Secures $500M to Boost AI Cybersecurity, Hits $3.4B Valuation

ReliaQuest, a leading AI-powered cybersecurity company, has raised over $500 million in a new funding round led by EQT, KKR, and FTV Capital, pushing its valuation to $3.4 billion. Other backers in this round include Ten...

GlobalFoundries and UMC Explore Merger Amid U.S. Chip Strategy Shift

United Microelectronics Corp. (UMC), a major Taiwanese semiconductor foundry, and U.S.-based GlobalFoundries (NASDAQ: GFS) are reportedly in early talks about a potential merger, according to sources cited by Reuters. If...

Intel CEO Lip-Bu Tan Outlines Bold Turnaround Strategy at IntelVision 2025

At the IntelVision 2025 conference, new Intel (NASDAQ: INTC) CEO Lip-Bu Tan unveiled a transformative vision to revitalize the tech giant. Since taking the helm on March 12, Tan has prioritized customer engagement and...

OpenAI Secures $40B from SoftBank, Reaches $300B Valuation Amid AI Boom

OpenAI announced Monday it has raised $40 billion in a funding round led by Japans SoftBank Group Corp. (TYO:9984), pushing the AI firms valuation to a staggering $300 billion. This marks a major leap from its $157 billion...